Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Differentiation Factor 15 Predictive Value, Prognostic Significance and Any Potential Correlation With Urea to Creatinine Ratio in Intensive Care Acquired Weakness

NCT06713746 is registered in ClinicalTrials.gov with Minia University as lead sponsor.

NCT NCT06713746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06713746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Differentiation Factor 15 Predictive Value, Prognostic Significance and Any Potential Correlation With Urea to Creatinine Ratio in Intensive Care Acquired Weakness
Lead sponsor
Minia University
Phase
Observational
Overall status
Completed
Start date
October 1, 2023
Completion date
November 1, 2024
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle weakness